ProvayBlue Drug Interactions
Currently displaying 129 drugs known to have a major interaction with ProvayBlue (methylene blue).
- 129 major drug interactions
- 65 moderate drug interactions
- 2 minor drug interactions
Major interactions with ProvayBlue (methylene blue)
Note: Showing generic names only.
5
A
B
C
D
- desipramine
- desvenlafaxine
- deutetrabenazine
- dexfenfluramine
- dexmethylphenidate
- dextroamphetamine
- dextromethorphan
- dezocine
- diethylpropion
- dihydroergotamine
- dolasetron
- dopamine
- doxapram
- doxepin
- doxepin topical
- doxylamine
- duloxetine
E
F
G
H
I
L
- lasmiditan
- levodopa
- levomethadyl acetate
- levomilnacipran
- levorphanol
- linezolid
- lisdexamfetamine
- lorcaserin
M
- ma huang
- maprotiline
- mazindol
- meperidine
- mephentermine
- metaraminol
- methadone
- methamphetamine
- methyldopa
- methylphenidate
- milnacipran
- mirtazapine
- morphine
- morphine liposomal
N
O
P
- palonosetron
- paroxetine
- pegulicianine
- pentazocine
- phendimetrazine
- phenelzine
- phentermine
- phenylephrine
- phenylpropanolamine
- propoxyphene
- protriptyline
- pseudoephedrine
R
S
T
- tapentadol
- tetrabenazine
- tetrahydrozoline nasal
- tolcapone
- tramadol
- tranylcypromine
- trazodone
- trimipramine
- tryptophan
- tyrosine
V
Z
ProvayBlue disease interactions
There are 2 disease interactions with ProvayBlue (methylene blue) which include:
More about ProvayBlue (methylene blue)
- ProvayBlue consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: antidotes
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.